Product Details
PPARΞ΄ Receptor Agonist & Metabolic Switch | Aerobic Endurance, Lipid Oxidation & Fast-Twitch Muscle Fiber Adaptation
Overview:
GW-501516 (Cardarine) is a selective Peroxisome Proliferator-Activated Receptor delta (PPARΞ΄) agonist engineered to switch cellular fuel utilization from glucose to free fatty acids. By upregulating key metabolic genes, GW-501516 dramatically increases lipid oxidation, boosts oxygen efficiency, improves serum lipid profiles, and enhances fatigue resistance by converting fast-twitch glycolytic muscle fibers into energy-efficient oxidative fibers.
This product is supplied as a secure bottle containing 50 oral tablets, with each tablet accurately dosed at 10mg of active GW-501516.
Why Choose GW-501516 (10mg) (50 Tablets)?
Unlike standard fat burners that rely on central nervous system stimulants, GW-501516 causes no jitters, elevated resting heart rate, or sleep disruption. It works directly at the gene-expression level to burn subcutaneous fat for fuel while preserving hard-earned lean muscle during deep caloric deficits.
Cardarine is widely recognized for driving extreme aerobic endurance and stamina, allowing for longer, more intense cardio and lifting sessions. The 10mg tablet configuration simplifies daily dosing routines, and 50 tablets provides a full supply for standard 6- to 8-week cutting and endurance protocols.
Key Benefits
- Accelerated Fatty Acid Oxidation: Forces body cells to burn stored lipids for energy rather than carbohydrates.
- Massive Endurance & Stamina: Drastically extends workout capacity, oxygen uptake, and time-to-exhaustion.
- Non-Stimulant Fat Loss: Drives weight loss without triggering thermogenic nervous system strain or heart palpitations.
- Lipid Profile Improvement: Promotes cardiovascular health by increasing good HDL cholesterol and lowering bad LDL/triglyceride levels.
- Non-Hormonal & Zero Suppression: Does not impact endogenous testosterone, LH, or estrogen levelsβno PCT required.
Administration & Usage Guidelines
- Half-Life & Timing: GW-501516 has an active elimination half-life of approximately 16 to 24 hours. It is taken once daily with water, ideally 30 to 45 minutes before exercise or in the morning.
- Protocol Duration: Standard research cycles range from 6 to 8 weeks, followed by an equal time off-cycle.
- Swallowing: Swallow tablets whole with water. Do not crush or chew.
Important Safety Points
- Non-Hormonal: Does not interact with androgen receptors, cause aromatization, or affect natural hormone production.
- Protocol Length: Stick to structured 6- to 8-week cycles to prevent cellular receptor downregulation.
- Hydration: Maintain optimal fluid and carbohydrate intake to support lipid transport and cellular performance.
Safety Notice
WARNING: Selective PPARΞ΄ receptor agonist. Non-hormonal compound; does not require Post-Cycle Therapy (PCT). Cap continuous use at 8 weeks maximum followed by a multi-week break. Strictly contraindicated in pregnant or breastfeeding individuals, or those with active liver dysfunction or malignant neoplasms.

Reviews
There are no reviews yet.